{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/28/3264184/0/fr/Communiqu%C3%A9-de-presse-AAD-Sanofi-pr%C3%A9sente-de-nouveaux-r%C3%A9sultats-de-phase-3-pour-l-amlitelimab-dans-la-dermatite-atopique-lors-d-une-session-de-derni%C3%A8re-minute.html", "message": "News view counter 632050 successfully enlarged"}